Danco, one of two U.S. companies that make the medicine, said that right now it has no plans to do so. The American College of Obstetricians and Gynecologists (ACOG) asked the FDA to invite Danco to submit a Supplemental New Drug Application (sNDA) for miscarriage management.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/jlGRcKm
0 Comments